Germline findings in patients with advanced malignancies screened with paired blood–tumour testing for personalised treatment approaches
European Journal of Cancer(2023)
摘要
•Significant amount of relevant germline variants is detected by blood-tumour testing.•Carriers do not always fulfil clinical criteria for cancer predisposition.•Blood–Tumour testing identifies novel links between cancer predisposition genes and cancer types.•Family-specific screening strategies are required when cancer predisposition genes are found in atypical tumours.
更多查看译文
关键词
Next-generation sequencing,Tumour–normal testing,Precision oncology,Personalised medicine,Cancer predisposition syndrome
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要